Elisa Aquilanti

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Venues

Neuro-oncology advances

Biochemical Society transactions

This page only lists publications with an associated author ORCID identifier.

Publications

Lauren Kageler, Elisa Aquilanti
Discovery of telomerase inhibitors: existing strategies and emerging innovations. Biochemical Society transactions 52 (4) (2024)
Elisa Aquilanti, Silvia Goldoni, Andrew Baker, Kristyna Kotynkova, Sawyer Andersen, Vincent Bozinov, Galen F Gao, Andrew D Cherniack, Martin Lange, Ralf Lesche, Charlotte Kopitz, Philip Lienau, Timothy A Lewis, Marine Garrido, Stefan Gradl, Henrik Seidel, Yuen-Yi Tseng, Keith L Ligon, Patrick Y Wen, Matthew Meyerson, Heidi Greulich
Velcrin molecular glues induce apoptosis in glioblastomas with high PDE3A and SLFN12 expression. Neuro-oncology advances 6 (1) (2024)
Elisa Aquilanti, Silvia Goldoni, Andrew Baker, Kristyna Kotynkova, Sawyer Andersen, Vincent Bozinov, Galen F Gao, Andrew D Cherniack, Martin Lange, Ralf Lesche, Charlotte Kopitz, Philip Lienau, Timothy A Lewis, Marine Garrido, Stefan Gradl, Henrik Seidel, Yuen-Yi Tseng, Keith L Ligon, Patrick Y Wen, Matthew Meyerson, Heidi Greulich
Velcrin molecular glues induce apoptosis in glioblastomas with high PDE3A and SLFN12 expression. Neuro-oncology advances 6 (1) (2024)
Elisa Aquilanti, Silvia Goldoni, Andrew Baker, Kristyna Kotynkova, Sawyer Andersen, Vincent Bozinov, Galen F Gao, Andrew D Cherniack, Martin Lange, Ralf Lesche, Charlotte Kopitz, Philip Lienau, Timothy A Lewis, Marine Garrido, Stefan Gradl, Henrik Seidel, Yuen-Yi Tseng, Keith L Ligon, Patrick Y Wen, Matthew Meyerson, Heidi Greulich
Velcrin molecular glues induce apoptosis in glioblastomas with high PDE3A and SLFN12 expression. Neuro-oncology advances 6 (1) (2024)

Elisa Aquilanti.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Elisa Aquilanti